Pioglitazone Improves Reversal Learning and Exerts Mixed Cerebrovascular Effects in a Mouse Model of Alzheimer’s Disease with Combined Amyloid-β and Cerebrovascular Pathology-Reference-Cited by-同舟云学术

Pioglitazone Improves Reversal Learning and Exerts Mixed Cerebrovascular Effects in a Mouse Model of Alzheimer’s Disease with Combined Amyloid-β and Cerebrovascular Pathology

Published:2013-07-18 Issue:7 Volume:8 Page:e68612
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Papadopoulos Panayiota,Rosa-Neto Pedro,Rochford Joseph,Hamel Edith

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference63 articles.

1. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer’s disease;RD Bell;Acta Neuropathol,2009

2. Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer’s disease brain;P Grammas;Am J Pathol,2002

3. A role for TGF-beta signaling in neurodegeneration: evidence from genetically engineered models;I Tesseur;Curr Alzheimer Res,2006

4. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer’s disease-like microvascular degeneration in transgenic mice;T Wyss-Coray;Am J Pathol,2000

5. Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer’s disease;B Ongali;Am J Pathol,2010

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer’s Disease and Other Neuropsychiatric Disorders: Promising Targets in a Therapeutic Strategy;International Journal of Molecular Sciences;2024-06-28

2. Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice;International Journal of Molecular Sciences;2023-06-14

3. A PDK-1 allosteric agonist improves spatial learning and memory in a βAPP/PS-1 transgenic mouse-high fat diet intervention model of Alzheimer's disease;Behavioural Brain Research;2023-02

4. Effects of Peroxisome Proliferator-Activated Receptor-Gamma Agonists on Cognitive Function: A Systematic Review and Meta-Analysis;Biomedicines;2023-01-18

5. Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation;European Journal of Pharmacology;2022-03